S.A. Mason LLC Buys 50 Shares of Stryker Co. (NYSE:SYK)

S.A. Mason LLC lifted its stake in Stryker Co. (NYSE:SYK) by 1.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,955 shares of the medical technology company’s stock after purchasing an additional 50 shares during the period. S.A. Mason LLC’s holdings in Stryker were worth $1,058,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in SYK. Burkett Financial Services LLC bought a new position in Stryker during the 4th quarter worth about $25,000. Farmers & Merchants Trust Co of Chambersburg PA grew its holdings in Stryker by 203.3% during the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock worth $27,000 after acquiring an additional 61 shares in the last quarter. Rogco LP bought a new position in Stryker during the 4th quarter worth about $30,000. DSM Capital Partners LLC bought a new position in Stryker during the 4th quarter worth about $34,000. Finally, HBC Financial Services PLLC bought a new position in Stryker during the 4th quarter worth about $37,000. 77.09% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. Stifel Nicolaus increased their target price on shares of Stryker from $350.00 to $375.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. Evercore ISI raised their price target on shares of Stryker from $340.00 to $370.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. The Goldman Sachs Group began coverage on shares of Stryker in a report on Thursday, May 30th. They issued a “neutral” rating and a $372.00 price target on the stock. Barclays raised their price target on shares of Stryker from $372.00 to $376.00 and gave the company an “overweight” rating in a report on Thursday, May 2nd. Finally, UBS Group raised their price target on shares of Stryker from $339.00 to $351.00 and gave the company a “neutral” rating in a report on Wednesday, May 1st. Four investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $370.58.

Stryker Stock Performance

SYK traded up $2.48 during trading on Thursday, reaching $342.99. 30,647 shares of the company’s stock were exchanged, compared to its average volume of 1,305,359. Stryker Co. has a 1 year low of $249.98 and a 1 year high of $361.41. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. The stock has a market capitalization of $130.66 billion, a P/E ratio of 38.90, a price-to-earnings-growth ratio of 2.67 and a beta of 0.92. The company’s fifty day simple moving average is $336.73 and its 200-day simple moving average is $332.95.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.36 by $0.14. The firm had revenue of $5.24 billion during the quarter, compared to analyst estimates of $5.10 billion. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The business’s quarterly revenue was up 9.7% on a year-over-year basis. During the same period in the previous year, the firm earned $2.14 EPS. As a group, research analysts predict that Stryker Co. will post 11.95 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be paid a $0.80 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.20 dividend on an annualized basis and a yield of 0.93%. Stryker’s dividend payout ratio is currently 36.53%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.